Zhuming Lu

542 total citations · 1 hit paper
13 papers, 261 citations indexed

About

Zhuming Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zhuming Lu has authored 13 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Zhuming Lu's work include RNA modifications and cancer (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Ferroptosis and cancer prognosis (4 papers). Zhuming Lu is often cited by papers focused on RNA modifications and cancer (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Ferroptosis and cancer prognosis (4 papers). Zhuming Lu collaborates with scholars based in China, Hungary and Germany. Zhuming Lu's co-authors include Shengshan Xu, Youbin Zheng, Xin Zhang, Ronggang Li, Lin Xiao, Aibin Liu, Dong Ren, Jiarong Chen, Zhihui Wang and Wenjie Lu and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Zhuming Lu

13 papers receiving 261 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis

2025 20 citations Shao‐Hua Yang, Youbin Zheng et al. Journal of Inflammation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhuming Lu China	8	163	128	59	54	34	13	261
Weiqing Lu China	5	185 1.1×	104 0.8×	96 1.6×	38 0.7×	48 1.4×	8	278
Zhenyu Ye China	8	176 1.1×	122 1.0×	60 1.0×	28 0.5×	53 1.6×	12	257
Zhicheng Yu China	10	207 1.3×	168 1.3×	50 0.8×	76 1.4×	38 1.1×	22	320
Shengda Cao China	12	229 1.4×	179 1.4×	46 0.8×	42 0.8×	17 0.5×	30	302
Qian Fei China	10	171 1.0×	151 1.2×	48 0.8×	48 0.9×	18 0.5×	19	264
Xue Lin Kwang Singapore	3	184 1.1×	156 1.2×	65 1.1×	22 0.4×	21 0.6×	5	250
Liming Gao China	13	316 1.9×	191 1.5×	55 0.9×	46 0.9×	26 0.8×	17	382
Alba Martínez United States	6	121 0.7×	112 0.9×	77 1.3×	47 0.9×	35 1.0×	10	287
Shuhui Bian China	5	166 1.0×	117 0.9×	111 1.9×	51 0.9×	52 1.5×	8	272
Nanbin Liu China	6	247 1.5×	211 1.6×	74 1.3×	102 1.9×	32 0.9×	14	339

Countries citing papers authored by Zhuming Lu

Since Specialization

Citations

This map shows the geographic impact of Zhuming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuming Lu more than expected).

Fields of papers citing papers by Zhuming Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuming Lu. The network helps show where Zhuming Lu may publish in the future.

Co-authorship network of co-authors of Zhuming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuming Lu. A scholar is included among the top collaborators of Zhuming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuming Lu. Zhuming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lu, Zhuming, et al.. (2025). Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation. Frontiers in Immunology. 16. 1540578–1540578. 1 indexed citations

Xu, Shengshan, Xiguang Chen, Hongyu Chu, et al.. (2025). Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses. BMC Cancer. 25(1). 1113–1113. 4 indexed citations

Yang, Shao‐Hua, Youbin Zheng, Hongyu Chu, et al.. (2025). The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis. Journal of Inflammation Research. Volume 18. 3757–3777. 20 indexed citations breakdown →

Liu, Xianqiang, Xiaowei Xi, Shengshan Xu, et al.. (2024). Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer. Frontiers in Immunology. 15. 1507501–1507501. 26 indexed citations

Xu, Shengshan, et al.. (2024). Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinoma. BMC Cancer. 24(1). 1138–1138. 20 indexed citations

Xu, Shengshan, et al.. (2024). Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response. BMC Cancer. 24(1). 1064–1064. 23 indexed citations

Lu, Zhuming, Shengshan Xu, Min Ye, et al.. (2024). Comparison of pembrolizumab plus chemotherapy versus concurrent or sequential radiochemotherapy in patients with driver mutation-lacking lung adenocarcinoma presenting with recurrent laryngeal nerve invasion leading to hoarseness.. Journal of Clinical Oncology. 42(16_suppl). e14635–e14635. 5 indexed citations

Xu, Shengshan, Hongyu Chu, Shuo Fang, et al.. (2023). Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Frontiers in Immunology. 14. 1155182–1155182. 16 indexed citations

Xu, Shengshan, Yuchen Liu, Shuo Fang, et al.. (2022). A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer. Frontiers in Genetics. 13. 834731–834731. 13 indexed citations

10.

Lu, Zhuming, Ming Ye, Tong Sun, et al.. (2022). Pembrolizumab for the better treatment of EGFR-mutant T790M-negative advanced lung adenocarcinoma patients than dual treatment of pemetrexed plus platinum after tyrosine kinase inhibitor treatment failure. Annals of Palliative Medicine. 11(6). 2100–2109. 4 indexed citations

11.

Chen, Jiarong, Aibin Liu, Zhihui Wang, et al.. (2020). LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. Molecular Cancer. 19(1). 98–98. 115 indexed citations

12.

Lu, Zhuming, et al.. (2018). MicroRNA‑137‑regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non‑small cell lung cancer. Oncology Letters. 16(2). 1876–1884. 10 indexed citations

13.

Lu, Zhuming, et al.. (2006). [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].. PubMed. 25(5). 604–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact